Alzheimer's drugs offer little benefit, major review finds. And the reasons go deeper than the science

How is it possible to spend tens of billions of dollars developing drugs to treat a serious disease that affects millions of people, and yet end up with something that does not work? This is a mystery that has bedeviled Alzheimer's research for years.